EUVIMEDEUVIMED entdecken
Übersichtsarbeit

In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy

Zheng Li, Jianhua Zou, Xiaoyuan Chen iD

Advanced Materials · 2023-05 · 35 (21)

DOI: 10.1002/adma.202209529 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 28.03.2023. Verfasst von Zheng Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and …. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 368 Literaturangaben. Gefördert von: National University of Singapore Startup Fund, NUS School of Medicine Nanomedicine Translational Research Program, Open Fund Young Individual Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging as a potent anticancer treatment, subcellular targeted cancer therapy has drawn increasing attention, bringing great opportunities for clinical application. Here, two targeting strategies for four main subcellular organelles (mitochondria, lysosome, endoplasmic reticulum, and nucleus), including molecule‐ and nanomaterial (inorganic nanoparticles, micelles, organic polymers, and others)‐based targeted delivery or therapeutic strategies, are summarized. Phototherapy, chemotherapy, radiotherapy, immunotherapy, and “all‐in‐one” combination therapy are among the strategies covered in detail. Such materials are constructed based on the specific properties and relevant mechanisms of organelles, enabling the elimination of tumors by inducing dysfunction in the corresponding organelles or destroying specific structures. The challenges faced by organelle‐targeting cancer therapies are also summarized. Looking forward, a paradigm for organelle‐targeting therapy with enhanced therapeutic efficacy compared to current clinical approaches is envisioned.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineNeoplasmsHumansDrug Delivery SystemsCell NucleusMitochondria

Stichwörter der Autor:innen

cancer therapymoleculesnanomaterialsprecision medicinesubcellular organelle targeting

Autor:innen und Institutionen

  • Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, 1…
  • Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
  • Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
  • Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore, 138673, Singapore.

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National University of Singapore Startup Fund
  • NUS School of Medicine Nanomedicine Translational Research Program
  • Open Fund Young Individual Research Grant
  • China Scholarship Council

Zitieren

APA

Li, Z., Zou, J., & Chen, X. (2023). In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy. Advanced Materials, 35(21). https://doi.org/10.1002/adma.202209529

Vancouver

Li Z, Zou J, Chen X. In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy. Advanced Materials. 2023;35(21). doi:10.1002/adma.202209529

BibTeX
@article{Li2023,
  author = {Li, Zheng and Zou, Jianhua and Chen, Xiaoyuan},
  title = {In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy},
  journal = {Advanced Materials},
  year = {2023},
  volume = {35},
  number = {21},
  doi = {10.1002/adma.202209529}
}
Kostenlos starten →